{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20240614",
          "review_priority": "UNKNOWN",
          "submission_class_code": "UNKNOWN",
          "application_docs": [
            {
              "id": "80205",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761286s001lbl.pdf",
              "date": "20241113",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20230626",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "74635",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761286s000lbl.pdf",
              "date": "20230627",
              "type": "Label"
            },
            {
              "id": "74641",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/761286Orig1s000ltr.pdf",
              "date": "20230627",
              "type": "Letter"
            },
            {
              "id": "74881",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/761286Orig1s000TOC.html",
              "date": "20230725",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "7",
          "submission_status": "AP",
          "submission_status_date": "20251209",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "84376",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761286Orig1s007ltr.pdf",
              "date": "20251210",
              "type": "Letter"
            },
            {
              "id": "84439",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761286s007lbl.pdf",
              "date": "20251218",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "BLA761286",
      "sponsor_name": "UCB INC",
      "openfda": {
        "application_number": [
          "BLA761286"
        ],
        "brand_name": [
          "RYSTIGGO"
        ],
        "generic_name": [
          "ROZANOLIXIZUMAB"
        ],
        "manufacturer_name": [
          "UCB, Inc."
        ],
        "product_ndc": [
          "50474-980",
          "50474-981",
          "50474-982",
          "50474-983"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "ROZANOLIXIZUMAB"
        ],
        "rxcui": [
          "2642288",
          "2642294",
          "2685614",
          "2685615",
          "2685616",
          "2685617",
          "2685618",
          "2685619"
        ],
        "spl_id": [
          "48d5f5c1-c45c-cb63-e063-6394a90a31c8"
        ],
        "spl_set_id": [
          "3c0eb8c2-c042-4954-b451-3baa77f5e6d1"
        ],
        "package_ndc": [
          "50474-980-79",
          "50474-981-83",
          "50474-982-84",
          "50474-983-86"
        ],
        "nui": [
          "N0000194004",
          "N0000194005"
        ],
        "pharm_class_epc": [
          "Neonatal Fc Receptor Blocker [EPC]"
        ],
        "pharm_class_moa": [
          "Neonatal Fc Receptor Blockers [MoA]"
        ],
        "unii": [
          "P7186074QC"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "RYSTIGGO",
          "active_ingredients": [
            {
              "name": "ROZANOLIXIZUMAB-NOLI",
              "strength": "280MG/2ML(140MG/ML)"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "SUBCUTANEOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}